In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates

Ravuconazole (BMS-207147, ER-30346) is a novel triazole with activity against Candida species, Cryptococcus neoformans, aspergilli, dermatophytes and other filamentous fungi [1–3]. The spectrum of ravuconazole includes yeast species (such as Candida krusei and Candida glabrata) that are non-susceptible to fluconazole. Candida albicans mutants with cumulative resistance to azoles may be susceptible to ravuconazole [4].